Sydnexis, Inc.
🇺🇸United States
- Country
- 🇺🇸United States
- Ownership
- Holding
- Established
- 2014-01-01
- Employees
- 11
- Market Cap
- -
The Safety and Efficacy of SYD-101 in Children With Myopia
Phase 3
Active, not recruiting
- Conditions
- Near-sightednessNear SightednessNearsightedness
- Interventions
- Drug: SYD-101 Dose 1Drug: SYD-101 Dose 2Drug: Vehicle
- First Posted Date
- 2019-04-18
- Last Posted Date
- 2025-04-09
- Lead Sponsor
- Sydnexis, Inc.
- Target Recruit Count
- 852
- Registration Number
- NCT03918915
- Locations
- 🇺🇸
Site 122, Fort Lauderdale, Florida, United States
🇺🇸Site 109, Jupiter, Florida, United States
🇺🇸Site 119, Sweetwater, Florida, United States
© Copyright 2025. All Rights Reserved by MedPath